José Alberto
Orfao de Matos Correia e Vale
Catedrático de Universidad
Consejo Superior de Investigaciones Científicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (47)
2023
-
Enhancement of Tumor Cell Immunogenicity and Antitumor Properties Derived from Platinum-Conjugated Iron Nanoparticles
Cancers, Vol. 15, Núm. 12
-
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice
Nature Communications, Vol. 14, Núm. 1
-
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Nature Communications, Vol. 14, Núm. 1
-
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study
Cytometry Part B - Clinical Cytometry
-
Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
Cancers, Vol. 15, Núm. 3
-
The International Consensus Classification of myelodysplastic syndromes and related entities
Virchows Archiv, Vol. 482, Núm. 1, pp. 39-51
2022
-
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
Blood Advances, Vol. 6, Núm. 3, pp. 774-784
-
Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model
Journal of Nanobiotechnology, Vol. 20, Núm. 1
-
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study
British Journal of Haematology, Vol. 197, Núm. 1, pp. 76-81
-
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1941-1950
-
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
Cancer research, Vol. 82, Núm. 6, pp. 1098-1109
-
Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
Frontiers in Immunology, Vol. 13
2021
-
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
Leukemia Research, Vol. 109
-
Deepening into intracellular signaling landscape through integrative spatial proteomics and transcriptomics in a lymphoma model
Biomolecules, Vol. 11, Núm. 12
-
Genomic heterogeneity of pancreatic ductal adenocarcinoma and its clinical impact
Cancers, Vol. 13, Núm. 17
-
Genomic profiling of sporadic liver metastatic colorectal cancer
Seminars in Cancer Biology, Vol. 71, pp. 98-108
-
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia
Leukemia, Vol. 35, Núm. 8, pp. 2358-2370
-
Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival
Brain Communications, Vol. 3, Núm. 1
-
Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma
Cancers, Vol. 13, Núm. 20
-
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions
HemaSphere, Vol. 5, Núm. 3, pp. E536